[Antiallergic effect of MY-5116 and its major metabolite, MY-1250].
D000818:Animals; D005260:Female; D006168:Guinea Pigs; D006633:Histamine Antagonists / Q000494:pharmacology*; D006634:Histamine H1 Antagonists / Q000494:pharmacology*; D006636:Histamine Release / Q000187:drug effects; D006801:Humans; D066298:In Vitro Techniques; D008168:Lung / Q000166:cytology / Q000276:immunology; D011804:Quinolines / Q000494:pharmacology*; D015363:Quinolones; D051381:Rats; D013189:SRS-A / Q000378:metabolism
D006633:Histamine Antagonists; D006634:Histamine H1 Antagonists; D011804:Quinolines; D015363:Quinolones; D013189:SRS-A; C048522:repirinast; C049488:MY 1250